Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcus Hoffmann

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Journal of Proteome Research|October 12, 2012
Glycoproteomic analysis of human fibrinogen reveals novel regions of O-glycosylationGerhild Zauner, Marcus Hoffmann, Erdmann Rapp, et al.
Journal of Proteome Research|February 10, 2015
The MetaProteomeAnalyzer: a powerful open-source software suite for metaproteomics data analysis and interpretationThilo Muth, Alexander Behne, Robert Heyer, et al.
Journal of Clinical Pharmacology|November 27, 2008
CYP2C19 genotype is a major factor contributing to the highly variable pharmacokinetics of voriconazoleJohanna Weiss, Magdalena Maria Ten Hoevel, Jürgen Burhenne, et al.
Omics : a Journal of Integrative Biology|September 16, 2016
SLCO1B1 Gene Variations Among Tanzanians, Ethiopians, and Europeans: Relevance for African and Worldwide Precision MedicineEleni Aklillu, Abiy Habtewold, Eliford Ngaimisi, et al.
Proteomics|May 17, 2012
MALDI-TOF-MS analysis of sialylated glycans and glycopeptides using 4-chloro-α-cyanocinnamic acid matrixMaurice H J Selman, Marcus Hoffmann, Gerhild Zauner, et al.
Basic & Clinical Pharmacology & Toxicology|October 8, 2014
The effect of induction of CYP3A4 by St John's wort on ambrisentan plasma pharmacokinetics in volunteers of known CYP2C19 genotypeChristoph Markert, Ida Maria Kastner, Regina Hellwig, et al.
Development (Cambridge, England)|June 9, 2021
A patient-based medaka alg2 mutant as a model for hypo-N-glycosylationSevinç Gücüm, Roman Sakson, Marcus Hoffmann, et al.
The Journal of Biological Chemistry|February 21, 2021
Glycosyltransferase POMGNT1 deficiency strengthens N-cadherin-mediated cell-cell adhesionSina Ibne Noor, Marcus Hoffmann, Natalie Rinis, et al.
Journal of Biotechnology|July 13, 2020
Synthesis of lipid-linked oligosaccharides by a compartmentalized multi-enzyme cascade for the in vitro N-glycosylation of peptidesThomas F T Rexer, Lisa Wenzel, Marcus Hoffmann, et al.
Molecular Genetics and Metabolism|April 12, 2026
Truncated N-glycans destabilize POMT1 and POMT2 but do not limit cellular O-mannosylation in HEK293 cellsDaniel Sturm, Christina Hölscher, Ivan Andújar Martínez, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Journal of Proteome Research|October 12, 2012
Glycoproteomic analysis of human fibrinogen reveals novel regions of O-glycosylationGerhild Zauner, Marcus Hoffmann, Erdmann Rapp, et al.
Journal of Proteome Research|February 10, 2015
The MetaProteomeAnalyzer: a powerful open-source software suite for metaproteomics data analysis and interpretationThilo Muth, Alexander Behne, Robert Heyer, et al.
Journal of Clinical Pharmacology|November 27, 2008
CYP2C19 genotype is a major factor contributing to the highly variable pharmacokinetics of voriconazoleJohanna Weiss, Magdalena Maria Ten Hoevel, Jürgen Burhenne, et al.
Omics : a Journal of Integrative Biology|September 16, 2016
SLCO1B1 Gene Variations Among Tanzanians, Ethiopians, and Europeans: Relevance for African and Worldwide Precision MedicineEleni Aklillu, Abiy Habtewold, Eliford Ngaimisi, et al.
Proteomics|May 17, 2012
MALDI-TOF-MS analysis of sialylated glycans and glycopeptides using 4-chloro-α-cyanocinnamic acid matrixMaurice H J Selman, Marcus Hoffmann, Gerhild Zauner, et al.
Basic & Clinical Pharmacology & Toxicology|October 8, 2014
The effect of induction of CYP3A4 by St John's wort on ambrisentan plasma pharmacokinetics in volunteers of known CYP2C19 genotypeChristoph Markert, Ida Maria Kastner, Regina Hellwig, et al.
Development (Cambridge, England)|June 9, 2021
A patient-based medaka alg2 mutant as a model for hypo-N-glycosylationSevinç Gücüm, Roman Sakson, Marcus Hoffmann, et al.
The Journal of Biological Chemistry|February 21, 2021
Glycosyltransferase POMGNT1 deficiency strengthens N-cadherin-mediated cell-cell adhesionSina Ibne Noor, Marcus Hoffmann, Natalie Rinis, et al.
Journal of Biotechnology|July 13, 2020
Synthesis of lipid-linked oligosaccharides by a compartmentalized multi-enzyme cascade for the in vitro N-glycosylation of peptidesThomas F T Rexer, Lisa Wenzel, Marcus Hoffmann, et al.
Molecular Genetics and Metabolism|April 12, 2026
Truncated N-glycans destabilize POMT1 and POMT2 but do not limit cellular O-mannosylation in HEK293 cellsDaniel Sturm, Christina Hölscher, Ivan Andújar Martínez, et al.
Pageof 5